Cantrell Drug Company recalls fentaNYL citrate in 0.9% Sodium Chloride Injection, 5 mcg/1 mL (5 mcg/mL), in a) 1 mL syringe (NDC 52533-214-45, UPC: 0…

Recall date

August 21, 2015

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-1156-2016

FDA classification

Class I

Brand / firm

Cantrell Drug Company

Sold / distributed

Nationwide

Why it was recalled

Subpotent Drug

Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.

What was recalled

fentaNYL citrate in 0.9% Sodium Chloride Injection, 5 mcg/1 mL (5 mcg/mL), in a) 1 mL syringe (NDC 52533-214-45, UPC: 0100352533214455) and b) 3 mL syringe (NDC 52533-214-60, UPC: 0100352533214608), Rx Only, Cantrell Drug Co., Little Rock, AR